# AMYLIN PHARMACEUTICALS INC

AMYLIN PHARMACEUTICALS INC is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** AMYLIN PHARMACEUTICALS INC
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000881464

## About

AMYLIN PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000881464, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2012-02-22, it reported annual revenue of USD 650,678,000; total assets of USD 1,870,199,000 for the fiscal period ended 2011-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2011 (period ended 2011-12-31)

- **Revenue:** $650.7M (USD 650,678,000)
- **Total assets:** $1.9B (USD 1,870,199,000)
- **Cash and equivalents:** $99.9M (USD 99,859,000)
- **Operating cash flow:** $88.3M (USD 88,302,000)

### FY2010 (period ended 2010-12-31)

- **Revenue:** $668.8M (USD 668,813,000)
- **Total assets:** $1.5B (USD 1,531,429,000)
- **Cash and equivalents:** $164.5M (USD 164,521,000)
- **Operating cash flow:** -$38.7M (USD -38,723,000)

## Recent SEC filings

- Form 8-K — filed 2012-08-13 — period 2012-08-08 — FORM 8-K
- Form 10-Q — filed 2012-08-03 — period 2012-06-30
- Form SC 13G — filed 2012-07-30 — AMYLIN PHARMACEUTICALS, INC.
- Form 8-K — filed 2012-07-03 — period 2012-06-29 — FORM 8-K
- Form 8-K — filed 2012-07-02 — period 2012-06-29 — FORM 8-K
- Form 8-K — filed 2012-06-18 — period 2012-06-18 — FORM 8-K
- Form 8-K — filed 2012-06-05 — period 2012-06-05 — FORM 8-K
- Form 8-K — filed 2012-05-16 — period 2012-05-15 — FORM 8-K
- Form 8-K — filed 2012-05-15 — period 2012-05-14 — FORM 8-K
- Form 10-Q — filed 2012-05-07 — period 2012-03-31 — FORM 10-Q
- Form 8-K — filed 2012-04-26 — period 2012-04-26 — FORM 8-K
- Form DEF 14A — filed 2012-04-12 — period 2012-05-15 — DEFINITIVE PROXY STATEMENT

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/amylin-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology